These findings support the concept that, in certain patients, sporadic neurodegenerative disorders may occur in genes that interact with known germline mutations—such as presenilin 1 in AD and leucine-rich repeat kinase 2 (LRRK2) in PD. This evidence concerns the gene LRRK2 and Alzheimer disease.